Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus.

[1]  Rick A. Bevins,et al.  Rats' novel object interaction as a measure of environmental familiarity , 2006 .

[2]  R. Bevins,et al.  Interoceptive Pavlovian conditioning with nicotine as the conditional stimulus varies as a function of the number of conditioning trials and unpaired sucrose deliveries , 2006, Behavioural pharmacology.

[3]  R. Bevins,et al.  Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats , 2006, Psychopharmacology.

[4]  W. Danysz,et al.  Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats , 2005, Neuropharmacology.

[5]  R. Bevins,et al.  Timing of conditioned responding in a nicotine locomotor conditioning preparation: manipulations of the temporal arrangement between context cues and drug administration , 2005, Behavioural Brain Research.

[6]  R. Bevins,et al.  Stimulus Properties of Nicotine, Amphetamine, and Chlordiazepoxide as Positive Features in a Pavlovian Appetitive Discrimination Task in Rats , 2005, Neuropsychopharmacology.

[7]  P. Sokoloff,et al.  Dopamine D3 Receptor Ligands Block Nicotine-Induced Conditioned Place Preferences through a Mechanism that does not Involve Discriminative-Stimulus or Antidepressant-Like Effects , 2005, Neuropsychopharmacology.

[8]  R. Kostrzewa,et al.  Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine. , 2005, Pharmacological reports : PR.

[9]  W. Danysz,et al.  Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats , 2005, Psychopharmacology.

[10]  P. Grillner,et al.  Nitric oxide is involved in nicotine-induced burst firing of rat ventral tegmental area dopamine neurons , 2004, Neuroscience.

[11]  M. Pilla,et al.  Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking. , 2004, European journal of pharmacology.

[12]  R. Bevins,et al.  Extending the role of associative learning processes in nicotine addiction. , 2004, Behavioral and cognitive neuroscience reviews.

[13]  M. Pietraszek,et al.  Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[14]  I. Gyertyán,et al.  Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011 , 2004, Behavioural pharmacology.

[15]  R. Bevins,et al.  Nicotine serves as a feature-positive modulator of Pavlovian appetitive conditioning in rats , 2004, Behavioural pharmacology.

[16]  R. Bevins,et al.  Nicotine as a signal for the presence or absence of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats , 2004, Psychopharmacology.

[17]  A. Harrison,et al.  Metabotropic Glutamate 5 Receptor Antagonist MPEP Decreased Nicotine and Cocaine Self‐Administration but Not Nicotine and Cocaine‐Induced Facilitation of Brain Reward Function in Rats , 2003, Annals of the New York Academy of Sciences.

[18]  R. Bevins,et al.  Nicotine-conditioned locomotor sensitization in rats: assessment of the US-preexposure effect , 2003, Behavioural Brain Research.

[19]  P. Conn,et al.  Metabotropic Glutamate Subtype 5 Receptors Modulate Locomotor Activity and Sensorimotor Gating in Rodents , 2003, Journal of Pharmacology and Experimental Therapeutics.

[20]  W. Löscher,et al.  Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats. , 2003, European journal of pharmacology.

[21]  D. Barber,et al.  Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats , 2003, Psychopharmacology.

[22]  F. Gasparini,et al.  The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice , 2003, Psychopharmacology.

[23]  T. Svensson,et al.  Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes. , 2003, The international journal of neuropsychopharmacology.

[24]  M. Geyer,et al.  The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity , 2002, Neuropharmacology.

[25]  S. Goldberg,et al.  Caffeine potentiates the discriminative-stimulus effects of nicotine in rats , 2002, Psychopharmacology.

[26]  Sang Eun Kim,et al.  Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat. , 2002, European journal of pharmacology.

[27]  A. Lajtha,et al.  Receptors in the Ventral Tegmental Area Mediating Nicotine-Induced Dopamine Release in the Nucleus Accumbens , 2002, Neurochemical Research.

[28]  A. Harrison,et al.  Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats , 2002, Psychopharmacology.

[29]  R. Papke,et al.  Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. , 2001, The Journal of pharmacology and experimental therapeutics.

[30]  R. Bevins,et al.  Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression , 2001, Pharmacology Biochemistry and Behavior.

[31]  T. Svensson,et al.  Putative role of presynaptic α7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area , 2000, Synapse.

[32]  S. Goldberg,et al.  Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose. , 2000, The Journal of pharmacology and experimental therapeutics.

[33]  W. Schmidt,et al.  Blockade of behavioral sensitization by MK-801: fact or artifact? , 2000, Psychopharmacology.

[34]  S. Berger,et al.  Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: Neuropharmacological characterization , 2000, Synapse.

[35]  A. Goudie,et al.  Does MK-801 Discrimination Constitute an Animal Model of Schizophrenia Useful for Detecting Atypical Antipsychotics? , 1999, Pharmacology Biochemistry and Behavior.

[36]  Roland Heckendorn,et al.  2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist , 1999, Neuropharmacology.

[37]  S. Goldberg,et al.  Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. , 1999, The Journal of pharmacology and experimental therapeutics.

[38]  A. Lajtha,et al.  Receptor systems participating in nicotine-specific effects , 1998, Neurochemistry International.

[39]  R. Mansbach,et al.  The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus. , 1998, Drug and alcohol dependence.

[40]  M. Millan,et al.  A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. , 1998, The Journal of pharmacology and experimental therapeutics.

[41]  M. Shoaib.  Is dopamine important in nicotine dependence? , 1998, Journal of Physiology-Paris.

[42]  M. Wolf,et al.  The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants , 1998, Progress in Neurobiology.

[43]  D. Bertrand,et al.  Open-Channel Blockers at the Human α4β2 Neuronal Nicotinic Acetylcholine Receptor , 1998 .

[44]  S. Goldberg,et al.  Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist , 1997, Psychopharmacology.

[45]  I. Stolerman,et al.  Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats , 1997, Psychopharmacology.

[46]  M. Papp,et al.  Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats , 1996, Pharmacology Biochemistry and Behavior.

[47]  G. Chiara,et al.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs , 1996, Nature.

[48]  Andrew N. Rowan.  Guide for the Care and Use of Laboratory Animals , 1996 .

[49]  P. Sokoloff,et al.  Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. , 1995, The Journal of pharmacology and experimental therapeutics.

[50]  L. Role,et al.  Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. , 1995, Science.

[51]  R. Corbett.  Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue , 1995, Pharmacology Biochemistry and Behavior.

[52]  T. Svensson,et al.  Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. , 1994, Pharmacology & toxicology.

[53]  W. Corrigall,et al.  Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area , 1994, Brain Research.

[54]  W. Corrigall,et al.  Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus , 1994, Pharmacology Biochemistry and Behavior.

[55]  M. Akbar,et al.  Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists , 1994, British journal of pharmacology.

[56]  A. Lajtha,et al.  NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study , 1994, Brain Research.

[57]  A. Lajtha,et al.  Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo , 1993, Neuropharmacology.

[58]  A. Lajtha,et al.  Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: Role of glutamic acid , 1992, Neurochemical Research.

[59]  M. Shoaib,et al.  MK801 attenuates behavioural adaptation to chronic nicotine administration in rats , 1992, British journal of pharmacology.

[60]  J. A. Dani,et al.  MK‐801 inhibition of nicotinic acetylcholine receptor channels , 1991, Synapse.

[61]  A. S. Ramoa,et al.  The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. , 1990, The Journal of pharmacology and experimental therapeutics.

[62]  J. A. Peters,et al.  The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK‐801: a voltage clamp study on neuronal cells in culture , 1989, British journal of pharmacology.

[63]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  L. Nowak,et al.  The role of divalent cations in the N‐methyl‐D‐aspartate responses of mouse central neurones in culture. , 1988, The Journal of physiology.

[65]  B. Bean,et al.  Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. Reavill,et al.  Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats , 1987, Journal of psychopharmacology.

[67]  G. Di Chiara,et al.  Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. , 1986, European journal of pharmacology.

[68]  L. Iversen,et al.  The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[69]  L. Snell,et al.  Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. , 1986, The Journal of pharmacology and experimental therapeutics.

[70]  P. H. Andersen,et al.  Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo. , 1986, Life sciences.

[71]  H. Hall,et al.  Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors. , 1986, European journal of pharmacology.

[72]  H. Hall,et al.  Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain. , 1985, European journal of pharmacology.

[73]  P. Fudala,et al.  Pharmacologic characterization of nicotine-induced conditioned place preference , 1985, Pharmacology Biochemistry and Behavior.

[74]  E. T. Iwamoto,et al.  Nicotine-induced taste aversion: Characterization and preexposure effects in rats , 1984, Pharmacology Biochemistry and Behavior.

[75]  A. Barnett,et al.  SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. , 1983, The Journal of pharmacology and experimental therapeutics.

[76]  R. Kumar,et al.  Characteristics of conditioned taste aversion produced by nicotine in rats , 1983, British journal of pharmacology.

[77]  J. Ayres,et al.  Stimulus-reinforcer and response-reinforcer relations in the control of conditioned appetitive headpoking (goal tracking) in rats. , 1979 .

[78]  P. W. Frey,et al.  Model of conditioning incorporating the Rescorla-Wagner associative axiom, a dynamic attention process, and a catastrophe rule. , 1978 .

[79]  W. Chance,et al.  A description of the nicotine stimulus and tests of its generalization to amphetamine , 1977, Psychopharmacology.

[80]  L. J. Roth,et al.  Entry and distribution of hexamethonium in the central nervous system. , 1971, Biochemical pharmacology.

[81]  J. Jongbloed.  Spectrophotometer investigation into the differences between fœtal and maternal hæmoglobin in man , 1938, The Journal of physiology.

[82]  I. Stolerman,et al.  Nicotine-induced place preferences following prior nicotine exposure in rats , 2005, Psychopharmacology.

[83]  J. Hyttel,et al.  Characterization of binding of3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions , 2005, Journal of Neural Transmission.

[84]  Jun Noguchi,et al.  Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. , 2004, Learning & memory.

[85]  I. Stolerman.  Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement , 2004, Psychopharmacology.

[86]  J. Pratt,et al.  Discriminative stimulus properties of nicotine: Further evidence for mediation at a cholinergic receptor , 2004, Psychopharmacology.

[87]  J. Stephenson,et al.  Nicotine injections as the conditioned stimulus in discrimination learning , 2004, Psychopharmacologia.

[88]  J. Pratt,et al.  Role of training dose in discrimination of nicotine and related compounds by rats , 2004, Psychopharmacology.

[89]  K. Kuschinsky,et al.  Conditioning of nicotine effects on motility and behaviour in rats , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[90]  P. Sokoloff,et al.  Disruption of nicotine conditioning by dopamine D3 receptor ligands , 2003, Molecular Psychiatry.

[91]  D. Bertrand,et al.  Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor. , 1998, Molecular pharmacology.

[92]  R. Todd,et al.  Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. , 1994, The Journal of pharmacology and experimental therapeutics.

[93]  R. Rescorla.  Behavioral studies of Pavlovian conditioning. , 1988, Annual review of neuroscience.

[94]  Hank Davis,et al.  Operant-Pavlovian Interactions , 1977 .

[95]  R. Rescorla,et al.  A theory of Pavlovian conditioning : Variations in the effectiveness of reinforcement and nonreinforcement , 1972 .

[96]  W. F. Prokasy,et al.  Classical conditioning II: Current research and theory. , 1972 .